Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Roxithromycin (150mg) + Serratiopeptidase (10mg) Tablet
Therapeutic Category
Antibacterials, Pulmonary, Respiratory
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Roxyfoli S Tablet containing Roxithromycin and Serratiopeptidase is used for the management of bacterial infections associated with swelling and inflammation. It helps support infection control and symptomatic relief.
Roxithromycin works as a macrolide antibiotic that inhibits bacterial growth, while Serratiopeptidase helps reduce inflammation, swelling, and tissue discomfort.
The tablet is widely prescribed in respiratory and general medicine practice for infection-related inflammatory conditions, leading to consistent prescription demand.
With increasing prevalence of respiratory infections and demand for combination therapies offering anti-inflammatory support, this product offers strong business potential for retailers and distributors. Its dual therapeutic action, broad clinical relevance, and steady market demand make it a reliable product for growth in the respiratory segment.
Some patients may experience nausea, abdominal discomfort, diarrhea, headache, dizziness, or skin rash. Rarely, allergic reactions, liver enzyme abnormalities, or gastrointestinal irritation may occur and require medical attention.
Roxyfoli S Tablet is indicated for respiratory tract infections, ENT infections, dental infections, skin and soft tissue infections, and other bacterial infections associated with inflammation and swelling. It helps control bacterial growth, reduce inflammation, relieve pain, and improve healing.
This medicine should be used under medical supervision. Complete the full prescribed antibiotic course to help prevent bacterial resistance. Use cautiously in patients with liver disorders or a history of gastrointestinal problems.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Acebrophylline (100mg) Capsule
Composition : Doxofylline (400mg) + Acebrophylline (100mg)
Composition : Acebrophylline (200mg) + Desloratadine (5mg) + Montelukast (10mg) Tablet
Composition : Levosalbutamol (1.25mg) + Ipratropium (500mcg)
Composition : Acebrophylline (200mg) + Montelukast (10mg)
Composition : Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg) (Sustained Release)
Composition : Acebrophylline (50mg) Syrup
Composition : Terbutaline (1.25mg/5ml) + Acebrophylline (50mg/5ml) + Guaifenesin (50mg/5ml) Syrup
Composition : Bilastin (20mg ) + Montelukast (10mg) + Acebrophylline (200mg) Sr Tab
Composition : Bilastine (10mg) + Acebrophylline (200mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Roxyfoli S Tablet, containing Roxithromycin 150mg and Serratiopeptidase 10mg, has strong demand in the respiratory and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on infection management and inflammatory care portfolios.
Medical distributors and agencies can benefit from the consistent demand for combination therapies used in respiratory tract infections, ENT infections, dental infections, and inflammatory conditions associated with bacterial infections. The addition of Serratiopeptidase helps reduce inflammation and swelling, strengthening a comprehensive anti-infective product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Roxyfoli S Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong prescription demand, reliable supply chain support, fast-moving anti-infective sales, and good margins when partnering for Roxyfoli S Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Roxyfoli S Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.